Johnson & Johnson Family of Companies
NEWS
Looking back over the past year and even decade, STAT News takes a look back at the best drugs approved over the past 10 years in its weekly Readout podcast.
Here are five high-quality examples of major bio organizations’ efforts to showcase their commitment to providing a positive D&I work environment.
The companies are facing questions in a criminal probe regarding their marketing distribution practices related to the sale of opioids.
It was a busy week for clinical trial announcements. Here’s a look.
In the Congo, there have been more than 3,000 cases and 2,000 related deaths to the Ebola virus outbreak.
When it comes to specific attributes, having the opportunity to do interesting and meaningful work, securing a competitive salary and having access to quality health benefits were the most important. Here are some differences when it comes to generational priorities.
Last week was busy for clinical trial news. Here’s a look.
Janssen Pharmaceutical of Johnson & Johnson released new long-term data from the open-label period of its Phase III VOYAGE 1 clinical trial.
Citing “sources familiar with the matter,” The Wall Street Journal reported that the agreement, should it be reached, would ultimately settle the matter for the company related to sales of Duragesic and Nucynta.
JOBS
IN THE PRESS